Ernexa Therapeutics embarks on new strategic direction, shifting the company’s focus from delivering a cell therapy platform to prioritizing product development New tagline to emphasize the company’s ...

For years, Alzheimer’s disease has been considered a brain disorder that leads to memory loss and cognitive decline. It’s a ...

The brain's immune cells removed plaques and helped restore a healthier environment in the brains of immunized patients. For over 30 years, scientists have focused on treating Alzheimer’s disease by ...

To raise awareness about leprosy, Purple Day is observed around the world. To mark the day, in this article, we have ...

Kezar Life Sciences reports positive Phase 2a data for zetomipzomib in autoimmune hepatitis, showing higher response rates and reduced steroid use.

RNA cancer vaccines are at the forefront of next-generation cancer immunotherapy, showcasing significant potential.

Suh Jin-seok targets 700 billion won for Jimpenetra as shipments double Suh Jin-seok anticipates substantial growth for ...

The global needles market is projected to grow from USD 8.1 billion in 2024 to USD 14.7 billion by 2035, at a CAGR of 6.1%.

The first patient has been dosed in the phase 3 TACTI-004 trial evaluating efti with Keytruda and chemotherapy for advanced ...

A recent study has revealed how Epstein-Barr virus (EBV) intensifies ulcerative colitis (UC), a debilitating inflammatory ...

Discover the top 10 risky factors that increase your chance of developing arthritis, from genetics to lifestyle choices, and ...

March is regonized as multiple sclerosis awareness month. One woman is shining a light on MS and sharing a message of hope ...